These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18780347)

  • 1. Membrane and membrane-associated proteins involved in the aggressive phenotype displayed by highly invasive cancer cells.
    Dowling P; Walsh N; Clynes M
    Proteomics; 2008 Oct; 8(19):4054-65. PubMed ID: 18780347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage.
    Baruthio F; Quadroni M; Rüegg C; Mariotti A
    Proteomics; 2008 Nov; 8(22):4733-47. PubMed ID: 18942674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front.
    Demir R; Dimmler A; Naschberger E; Demir I; Papadopoulos T; Melling N; Sturzl M; Hohenberger W
    Exp Mol Pathol; 2009 Oct; 87(2):109-16. PubMed ID: 19481539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasion and metastasis.
    Carr I; Orr FW
    Can Med Assoc J; 1983 May; 128(10):1164-7. PubMed ID: 6340812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
    Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
    Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factors control invasion: AP-1 the first among equals.
    Ozanne BW; Spence HJ; McGarry LC; Hennigan RF
    Oncogene; 2007 Jan; 26(1):1-10. PubMed ID: 16799638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
    Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
    Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
    Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
    J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMT, the cytoskeleton, and cancer cell invasion.
    Yilmaz M; Christofori G
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):15-33. PubMed ID: 19169796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.
    Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A
    Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
    Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
    Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular regulation of an invasion-related molecule--options for tumour staging and clinical strategies.
    Allgayer H
    Eur J Cancer; 2006 May; 42(7):811-9. PubMed ID: 16617013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarity proteins in migration and invasion.
    Etienne-Manneville S
    Oncogene; 2008 Nov; 27(55):6970-80. PubMed ID: 19029938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic behaviour in malignant invasion.
    Marchant BP; Norbury J; Byrne HM
    Math Med Biol; 2006 Sep; 23(3):173-96. PubMed ID: 16627537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravital imaging and cell invasion.
    Makale M
    Methods Enzymol; 2007; 426():375-401. PubMed ID: 17697892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.
    Koga F; Kihara K; Neckers L
    Anticancer Res; 2009 Mar; 29(3):797-807. PubMed ID: 19414312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.